AETHLON MEDICAL, INC. (AEMD) Return on equity 2017–2024
AETHLON MEDICAL, INC. (AEMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-211.7%FY2024 · since FY2017: -1075.7% → -211.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -211.7% | -131.9 pp |
| FY2023 | -79.9% | -18.6 pp |
| FY2022 | -61.3% | +22.3 pp |
| FY2021 | -83.6% | -15.9 pp |
| FY2020 | -67.7% | +187.7 pp |
| FY2019 | -255.4% | -162.9 pp |
| FY2018 | -92.6% | +983.2 pp |
| FY2017 | -1075.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice